https://www.selleckchem.com/
To elucidate a novel molecular mechanism of MAIR-II, we considered macrophage activation by Toll-like receptor (TLR) 9-mediated inflammation. In vitro, we observed that Cd300c2-/- bone marrow-derived macrophages stimulated by a TLR9 agonist expressed less pro-inflammatory cytokines compared to WT. In conclusion, MAIR-II may enhance inflammation via TLR9-mediated macrophage activation in MI, leading to adverse cardiac remodelling and poor prognosis.A series of high-efficiency narrow band red-emitting La2 M2 O9 Eu3+ (M = Mo/W) phosphors for white LEDs was syn
Aimer
Commentaire
Partagez
